Can we afford to ignore missing data in cost-effectiveness analyses?

European Journal of Health Economics

Volumn 10, Issue 1, 2009, Pages 1-3

  Marshall, Andrea ^a   Billingham, Lucinda J ^b   Bryan, Stirling ^b  

^a UNIVERSITY OF WARWICK   (United Kingdom)

^b UNIVERSITY OF BIRMINGHAM   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CISPLATIN; IFOSFAMIDE; MITOMYCIN;

CANCER CHEMOTHERAPY; CANCER PALLIATIVE THERAPY; CANCER SURVIVAL; CLINICAL TRIAL; COST EFFECTIVENESS ANALYSIS; COST UTILITY ANALYSIS; DATA ANALYSIS; DATA BASE; DRUG COST; EDITORIAL; HEALTH CARE COST; HUMAN; LUNG NON SMALL CELL CANCER; PRACTICE GUIDELINE; PRIORITY JOURNAL; SURVIVAL TIME;

COST-BENEFIT ANALYSIS; HEALTH CARE COSTS; HUMANS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RESEARCH DESIGN; SELECTION BIAS;

EID: 58149096572     PISSN: 16187598     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10198-008-0129-y     Document Type: Editorial

References (28)

1. J Munro J Nicholl J Brazier R Davey T Cochrane 2004 Cost effectiveness of a community based exercise programme in over 65 year olds: cluster randomised trial J Epidemiol Community Health 58 1004 1010
2. A Harris E Gospodarevskaya A Ritter 2005 A randomised trial of the cost effectiveness of buprenorphine as an alternative to methadone maintenance treatment for heroin dependence in a primary care setting Pharmacoeconomics 23 77 91
3. O Rivero-Arias H Campbell A Gray J Fairbank H Frost J Wilson-MacDonald 2005 Surgical stabilisation of the spine compared with a programme of intensive rehabilitation for the management of patients with chronic low back pain: cost utility analysis based on a randomised controlled trial BMJ 330 1239 1243
4. LJ Billingham S Bathers A Burton S Bryan MH Cullen 2002 Patterns, costs and cost-effectiveness of care in a trial of chemotherapy for advanced non-small cell lung cancer Lung Cancer 37 219 225
5. D Wonderling A Vickers R Grieve R McCarney 2004 Cost effectiveness analysis of a randomised trial of acupuncture for chronic headache in primary care BMJ 328 747
6. M Drummond T Jefferson 1996 Guidelines for authors and peer reviewers of economic submissions to the BMJ BMJ 313 275 283
7. T Jefferson R Smith Y Yee M Drummond M Pratt R Gale 1998 Evaluating the BMJ guidelines for economic submissions: prospective audit of economic submissions to BMJ and The Lancet JAMA 280 275 277
8. A Burton DG Altman 2004 Missing covariate data within cancer prognostic studies: a review of current reporting and proposed guidelines Br J Cancer 91 4 8
9. AM Wood IR White SG Thompson 2004 Are missing outcome data adequately handled? A review of published randomized controlled trials in major medical journals Clin Trials 1 368 376
10. Little, R.J.A., Rubin, D.B.: Statistical analysis with missing data. Wiley, New York (1987)
11. Rubin, D.B.: Multiple imputation for nonresponse in surveys. Wiley, New York (1987)
12. Schafer, J.L.: Analysis of incomplete multivariate data. Chapman & Hall, New York (1997)
13. Harrell, F.E.: Regression modeling strategies with applications to linear models, logistic regression, and survival analysis. Springer, New York (2001)
14. S van Buuren HC Boshuizen DL Knook 1999 Multiple imputation of missing blood pressure covariates in survival analysis Stat Med 18 681 694
15. Little, R.J.A., Rubin, D.B.: Statistical analysis with missing data, 2nd edn. Wiley, New York (2002)
16. A Briggs T Clark J Wolstenholme P Clarke 2003 Missing... presumed at random: cost-analysis of incomplete data Health Econ 12 377 392
17. LM Yu A Burton O Rivero-Arias 2007 Evaluation of software for multiple imputation of semi-continuous data Stat Methods Med Res 16 243 258
18. P Royston 2004 Multiple imputation of missing values Stata J 4 227 241
19. P Royston 2005 Multiple imputation of missing values: update Stata J 5 188 201
20. P Royston 2005 Multiple imputation of missing values: update of ice Stata J 5 527 536
21. S van Buuren CGM Oudshoorn 2005 Mice: multivariate imputation by chained equations library R Stat Softw Ver 1 13 1
22. MG Kenward J Carpenter 2007 Multiple imputation: current perspectives Stat Methods Med Res 16 199 218
23. A Burton L Billingham S Bryan 2007 Cost-effectiveness in clinical trials: using multiple imputation to deal with incomplete cost data Clin Trials 4 154 161
24. UK BEAM Trial Team 2004 United Kingdom back pain exercise and manipulation (UK BEAM) randomised trial: cost effectiveness of physical treatments for back pain in primary care BMJ 329 1381 1385
25. MH Cullen LJ Billingham CM Woodroffe AD Chetiyawardana NH Gower R Joshi DR Ferry RM Rudd SG Spiro JE Cook C Trask E Bessell CK Connolly J Tobias RL Souhami 1999 Mitomycin, ifosfamide, and cisplatin in unresectable non-small-cell lung cancer: effects on survival and quality of life J Clin Oncol 17 3188 3194
26. A Manca S Palmer 2005 Handling missing data in patient-level cost-effectiveness analysis alongside randomised clinical trials Appl Health Econ Health Policy 4 65 75
27. H Bang A Tsiatis 2000 Estimating medical costs with censored data Biometrika 87 329 343
28. P Royston 2007 Multiple imputation of missing values: further update of ice, with an emphasis on interval censoring Stata J 7 445 464